3112 Nintedanib in combination with cisplatin/gemcitabine as 1st-line therapy for advanced squamous non-small cell lung cancer. (September 2015) - Forster, M.; Hackshaw, A.; Pas, T. De; Cobo, M.; Garrido, P.; Summers, Y.; Dingemans, A.M.; Flynn, M.; Von Wangenheim, U.; Temple, G.; Loembé, A.B.; Lee, S.M.